Owl Creek Asset Management L.P. decreased its position in Danaher Corporation (NYSE:DHR – Free Report) by 45.4% in the 1st quarter, HoldingsChannel reports. The firm owned 34,653 shares of the conglomerate’s stock after selling 28,790 shares during the period. Danaher makes up about 0.5% of Owl Creek Asset Management L.P.’s holdings, making the stock its 17th largest holding. Owl Creek Asset Management L.P.’s holdings in Danaher were worth $6,570,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Main Street Group LTD purchased a new stake in shares of Danaher during the first quarter worth about $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher during the fourth quarter worth approximately $26,000. WFA of San Diego LLC acquired a new stake in Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher in the 4th quarter worth approximately $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Stock Up 0.2%
Shares of NYSE DHR opened at $191.87 on Monday. The stock has a market capitalization of $134.88 billion, a PE ratio of 34.08, a P/E/G ratio of 2.38 and a beta of 0.79. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm has a fifty day moving average of $185.64 and a 200-day moving average of $196.76. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s dividend payout ratio is currently 28.42%.
Analyst Ratings Changes
Several brokerages have weighed in on DHR. Piper Sandler assumed coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. UBS Group dropped their target price on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, Stifel Nicolaus lowered their price target on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.
Read Our Latest Stock Report on DHR
Trending Headlines about Danaher
Here are the key news stories impacting Danaher this week:
- Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
- Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
- Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
- Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
- Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
